* Oscar Health Inc OSCR.N reported a quarterly adjusted
loss
of 18 cents per share for the quarter ended in March. The mean
expectation of seven analysts for the quarter was for a loss
of 5 cents per share.
* Revenue rose 51.1% to $1.47 billion from a year ago;
analysts
expected $1.15 billion.
* Oscar Health Inc's reported EPS for the quarter was a loss
of 18
cents.
* The mean earnings estimate of analysts had fallen by
about 245%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Oscar Health Inc shares had risen by 15.0% this
quarter and
gained 205.7% so far this year.
* The company reported a quarterly loss of $39.77 million.
* Wall Street's median 12-month price target for Oscar
Health Inc
is $5.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
9 at 10:05 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.05 -0.18 Missed
Dec. 31 2022 -1.16 -1.05 Beat
Sep. 30 2022 -0.73 -0.91 Missed
Jun. 30 2022 -0.48 -0.53 Missed